Ultragenyx Pharmaceutical, Inc. $(RARE)$ is currently at $29.15, down $1.07 or 3.54%
--Would be lowest close since June 24, 2026, when it closed at $29.11
--On pace for largest percent decrease since July 16, 2026, when it fell 4.7%
--Currently down eight consecutive days; down 18.73% over this period
--Longest losing streak since Dec. 18, 2024, when it fell for eight straight trading days
--Worst eight day stretch since the eight days ending Jan. 8, 2026, when it fell 32.11%
--Down 13.81% this week; worst weekly performance since the week ending Feb. 13, 2026, when it fell 16.92%
--Down 12.7% month-to-date
--Up 26.74% year-to-date
--Down 83.57% from its all-time closing high of $177.39 on Dec. 23, 2020
--Up 10.79% from 52 weeks ago (July 18, 2025), when it closed at $26.31
--Down 20.22% from its 52-week closing high of $36.54 on Dec. 4, 2025
--Up 57.57% from its 52-week closing low of $18.50 on March 24, 2026
--Traded as low as $28.90; lowest intraday level since June 23, 2026, when it hit $28.50
--Down 4.37% at today's intraday low
All data as of 3:33:11 PM ET
Source: Dow Jones Market Data, FactSet
(END) Dow Jones Newswires
July 17, 2026 15:35 ET (19:35 GMT)
Copyright (c) 2026 Dow Jones & Company, Inc.
Comments